Diamonds and Dogs

1/13/22

Delta (DAL) trading higher following earnings. Delta is up 3% following better than expected earnings as revenues rose 138% year over year to $9.47 billion. Delta is still struggling with the pandemic as 8000 employees have tested positive for COVID over the last four weeks. Going forward, business should only improve. Delta received an upgrade with a $50 price target.

Profit-taking in Abbot Labs (ABT). The maker of the at-home-test for COVID-19 has performed well through the pandemic, but the stock is down a percent today and down 7% to start the year as many are predicting the Omicron variant has peaked at least in the Northeast. Having said that, the Biden administration has committed to buying a billion COVID-19 tests to distribute to schools and other areas.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.